Mesh Bio
Singapore’s Mesh Bio attains regulatory approval for HealthVector Diabetes
Singapore-founded health technology startup Mesh Bio has announced the regulatory approval of its HealthVector® Diabetes as a Software Medical Device (SaMD) by the Health Sciences…
Singaporean health deep tech startup Mesh Bio secures investment from East Ventures
Mesh Bio, a Singapore-based health deep tech startup, announced Thursday that it had raised an undisclosed amount of funding from East Ventures, a venture capital firm focusing on…
